HYPERTENSION CONTROL If the pt is a thrombolysis candidate - BP control should be initiated immediately Short acting ,IV , titratable antihypertensives agents Labetalol, 10–20 mg IV over 1–2 min, can double the dose every 10min up to 300mg Contraindications/caution: severe asthma, severe COPD, CHF, DM, myasthenia gravis, concurrent calcium channel blocker use, hepatic insufficiency. Nicardipine infusion, 5 mg/h, titrate up by 2.5 milligrams/h at 5- to 15-min intervals; Maximum dose: 15 MG/h; when desired blood pressure attained, reduce to 3 milligrams/h Caution: MI , concurrent use of fentanyl (hypotension), CHF, hypertrophic cardiomyopathy, portal hypertension, renal insufficiency, hepatic insufficiency (may need to adjust starting dose). Contraindication : severe aortic stenosis. Clevidipine infusion, 1–2 milligrams/h, titrate up by doubling dose every 2–5 min; maximum dose:21 milligrams/h Caution: CHF. Can cause reflex tachycardia atrial fibrillation, and systemic hypotension. Contraindication : severe aortic stenosis. L ipid metabolism disorders (e.g., pathologic hyperlipidemia, lipoid nephrosis, or acute pancreatitis with hyperlipidemia). NTG infusion CCBs